Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice
Recent research shows that the current limit (200 ng/ml) is probably too low
doi: 10.1210/jcem.87.5.8628
doi: 10.1007/s00702-006-0485-7
Many patients achieve remission or low disease state, which can be attributed to the development of specific DMARDs
Airtight Seal: The container holding the bacteriostatic water must be kept tightly sealed to prevent the introduction of contaminants, such as airborne bacteria or dust particles